Revvity, Inc. RVTY
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-03T14:44:17.293Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T14:44:15.902541454Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-03T14:44:16.819859+00:00
Revvity, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 187.09 | 48.4% | 11.2% | 152.23 | 67.0% | 12.2% |
| 25Δ | 183.70 | 48.2% | 9.6% | 156.91 | 61.7% | 9.8% |
| 30Δ | 181.16 | 49.4% | 8.5% | 160.91 | 56.3% | 7.8% |
| 35Δ | 178.63 | 50.1% | 7.5% | 163.69 | 55.9% | 6.8% |
| 40Δ | 176.11 | 50.3% | 6.5% | 166.36 | 55.2% | 5.8% |
| 45Δ | 173.69 | 51.0% | 5.7% | 168.92 | 54.4% | 4.9% |
| 50Δ | 171.34 | 52.1% | 5.0% | 171.47 | 54.1% | 4.2% |
| 55Δ | 168.94 | 52.8% | 4.4% | 174.01 | 54.1% | 3.5% |
| 60Δ | 166.48 | 53.1% | 3.7% | 176.59 | 53.8% | 2.9% |
| 65Δ | 163.95 | 53.3% | 3.1% | 179.20 | 53.3% | 2.4% |
| 70Δ | 161.31 | 53.4% | 2.5% | 181.78 | 51.9% | 1.8% |
| 75Δ | 158.01 | 55.8% | 2.1% | 184.33 | 50.3% | 1.4% |
| 80Δ | 154.01 | 59.6% | 1.7% | 187.30 | 49.0% | 0.9% |
20Δ
- Pseudo strike
- 187.09
- IV
- 48.4%
- B/E move
- 11.2%
- Pseudo strike
- 152.23
- IV
- 67.0%
- B/E move
- 12.2%
25Δ
- Pseudo strike
- 183.70
- IV
- 48.2%
- B/E move
- 9.6%
- Pseudo strike
- 156.91
- IV
- 61.7%
- B/E move
- 9.8%
30Δ
- Pseudo strike
- 181.16
- IV
- 49.4%
- B/E move
- 8.5%
- Pseudo strike
- 160.91
- IV
- 56.3%
- B/E move
- 7.8%
35Δ
- Pseudo strike
- 178.63
- IV
- 50.1%
- B/E move
- 7.5%
- Pseudo strike
- 163.69
- IV
- 55.9%
- B/E move
- 6.8%
40Δ
- Pseudo strike
- 176.11
- IV
- 50.3%
- B/E move
- 6.5%
- Pseudo strike
- 166.36
- IV
- 55.2%
- B/E move
- 5.8%
45Δ
- Pseudo strike
- 173.69
- IV
- 51.0%
- B/E move
- 5.7%
- Pseudo strike
- 168.92
- IV
- 54.4%
- B/E move
- 4.9%
50Δ
- Pseudo strike
- 171.34
- IV
- 52.1%
- B/E move
- 5.0%
- Pseudo strike
- 171.47
- IV
- 54.1%
- B/E move
- 4.2%
55Δ
- Pseudo strike
- 168.94
- IV
- 52.8%
- B/E move
- 4.4%
- Pseudo strike
- 174.01
- IV
- 54.1%
- B/E move
- 3.5%
60Δ
- Pseudo strike
- 166.48
- IV
- 53.1%
- B/E move
- 3.7%
- Pseudo strike
- 176.59
- IV
- 53.8%
- B/E move
- 2.9%
65Δ
- Pseudo strike
- 163.95
- IV
- 53.3%
- B/E move
- 3.1%
- Pseudo strike
- 179.20
- IV
- 53.3%
- B/E move
- 2.4%
70Δ
- Pseudo strike
- 161.31
- IV
- 53.4%
- B/E move
- 2.5%
- Pseudo strike
- 181.78
- IV
- 51.9%
- B/E move
- 1.8%
75Δ
- Pseudo strike
- 158.01
- IV
- 55.8%
- B/E move
- 2.1%
- Pseudo strike
- 184.33
- IV
- 50.3%
- B/E move
- 1.4%
80Δ
- Pseudo strike
- 154.01
- IV
- 59.6%
- B/E move
- 1.7%
- Pseudo strike
- 187.30
- IV
- 49.0%
- B/E move
- 0.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 40.54% | |
| 40.77% | |
| 40.85% | |
| 40.39% | |
| 41.05% | |
| 39.30% | |
| 39.02% | |
| 38.61% | |
| 39.49% | |
| 41.69% | |
| 42.02% | |
| 38.45% | |
| 39.30% | |
| 38.79% | |
| 37.89% | |
| 37.07% | |
| 37.01% | |
| 36.51% | |
| 37.37% | |
| 36.38% | |
| 37.36% | |
| 37.07% | |
| 41.08% | |
| 42.41% | |
| 41.38% | |
| 40.39% | |
| 41.18% | |
| 45.96% | |
| 45.15% | |
| 39.24% | |
| 40.06% | |
| 39.93% | |
| 40.02% | |
| 40.29% | |
| 40.92% | |
| 43.44% | |
| 43.63% | |
| 44.62% | |
| 44.41% | |
| 44.05% | |
| 43.79% | |
| 47.06% | |
| 47.58% | |
| 47.16% | |
| 46.97% | |
| 49.72% | |
| 50.67% | |
| 51.16% | |
| 52.26% | |
| 47.66% | |
| 47.40% | |
| 46.96% | |
| 47.84% | |
| 47.93% | |
| 48.06% | |
| 48.24% | |
| 48.44% | |
| 48.09% | |
| 50.03% | |
| 50.57% |
Diagnostics & Research
SHC
Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and…
More →TMO
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other…
More →VCYT
Description unavailable
More →WAT
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
More →WGS
Sema4 Holdings Corp. The company is headquartered in Stamford, Connecticut.
More →XGN
Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name in the United States. The…
More →